{"data":{"type":"company_profile","id":15182,"entity_id":"wefunder:company:15182","attributes":{"canonical_url":"https://wefunder.com/neurohacker","generated_at":"2026-06-07T03:40:30Z","updated_at":"2026-06-06T05:00:41Z","entity_ids":{"company":"wefunder:company:15182","slug":"wefunder:company_slug:neurohacker"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-07T03:40:30Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-06T05:00:41Z","as_of":"2026-06-07T03:40:30Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-06T05:00:41Z","as_of":"2026-06-07T03:40:30Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-07T03:40:30Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-07T03:40:30Z","confidence":"medium"}}},"company":{"id":15182,"entity_id":"wefunder:company:15182","slug":"neurohacker","name":"Qualia Life Sciences","tagline":"Creating meaningful and sustainable \r\nupgrades to personal well-being","elevator_pitch":"Founded in 2015, our mission is to create best in class well-being products by employing a unique methodology to research and development based on complex systems science. Rather than overriding regulatory systems with chemicals designed to move a biomarker in a particular direction, this approach focuses on supporting the body’s ability to self-regulate.","story":"Neurohacker Collective aims to provide meaningful scientific advances through a deeper understanding of human biology. We started with supplements for the mind (known as “nootropics”), which is a rapidly growing industry with global sales of $1.35 billion and expected growth to $6.1 billion by 2025. In the creation of our Qualia nootropics product line, we set out to make a supplement radically different than all other nootropics on the market. Many nootropics focus only on short-term effects. Instead of focusing on improving a single aspect such as memory, Qualia addresses long-term brain health and encourages new neuron and synapse development for a stronger brain.While choosing from hundreds of ingredients that could serve our purpose, we took into account how a set of ingredients, as a whole, would support each physiological outcome we wanted to promote and the cognitive and subjective outcomes we sought to enhance, as well as general effects on the rest of the body. This careful and laborious formulation process lead to the creation of Qualia Mind\u0026nbsp;that has unquestionably established itself as the market leader. With abundant support from some of the world’s most recognized and respected doctors, healthcare practitioners, scientists, health and wellness leaders and our customers, our revenues continue to climb with 91% of product revenue being subscription-driven (excluding Amazon and wholesale). The reason our company has a uniquely explosive value potential is that our complex systems science modeling (which can't be easily replicated by other wellness companies without the brain trust we've assembled) can be applied to a bevy of products. This has us positioned to create best in class supplement products across a variety of health needs in the near future, in an industry estimated to be worth 578 billion dollars within 5 years. We are also planning to develop solutions for sleep, anxiety/mood, pain, immune function, fitness performance, hormone balancing, and cardiovascular health.$20,000,000+ in Total Sales So FarGrowing Revenues and Profit ContributionRevenues and Profit Contribution Margin by bi-annual period. Profit Contribution is defined as sales revenues less costs of goods and advertising expenses. In 2019, Neurohacker reached profitability (on EBITDA basis).A World-Class Product Development EngineWe are deeply focused on the complex systems modeling necessary to deliver real efficacy at scale in the nutraceutical space, always with the overarching intention to support the human body’s natural ability to regulate while working to help increase its capacity.\u0026nbsp;TOP SCIENTISTS \u0026amp; MDS:\u0026nbsp;Our products are developed by top scientists in complex-systems modeling, neurobiology, organic chemistry as well as dozens of MDs and PhDs.RESEARCH-BACKED INGREDIENTS:\u0026nbsp;All our ingredients are chosen based on the strong empirical basis of their safety.FULL TRANSPARENCY:\u0026nbsp;We are 100% transparent. No proprietary blends. We fully publish the research behind every product.PURITY \u0026amp; POTENCY:\u0026nbsp;We take great care to use the most potent, high-purity, and bioavailable forms of each ingredient that are gluten-free and non-GMOWe Have 6 Products, By the End of 2020 We Plan to Have at Least 8Radical Cognitive EnhancementQUALIA FOCUS \u0026amp; QUALIA MIND are premier, research-based nootropics that help support mental performance and brain health. Specifically designed to promote focus, support energy, mental clarity, mood, memory, and creativity.\u0026nbsp;\u0026nbsp;In addition to immediate neurochemical and physiological effects, Qualia nootropics go a step further addressing long-term cognitive health benefits.Pilot Study Using Qualia Mind Shows Meaningful Positive ResultsThe results for 23 eligible subjects revealed meaningful improvement in core cognitive areas of reasoning, verbal ability and concentration. After 5 days of taking Qualia Mind, participants saw an average 85.4% increase in scores to measure ability to concentrate/avoid distraction, 37.2% increase in scores for planning skills, 31.1% increase in scores for visual representation, 16.9% increase in scores for verbal reasoning, 13.3% increase in scores for verbal short-term memory, and 10.2% increase in scores for episodic memory. Given that this study did not have a placebo control, we cannot conclusively determine whether or not Qualia Mind is the cause of the increased scores. See additional details on the study here.\u0026nbsp;We are in the process of conducting a double-blinded, placebo-controlled clinical study of Qualia Mind to confirm these results.Eternus: Our Breakthrough in AgingEternus, is specifically designed to combat the aging process in the most comprehensive way ever developed from a supplement product. Eternus 36+ high-purity and powerful nutrients to\u0026nbsp;boost NAD+, ATP, \u0026amp; AMPK production, support mitochondrial fitness \u0026amp; cell energy, amplify productivity, promote restful sleep, upgrade energy levels, and provide support for handling stress. More cell energy leads to sounder sleep, increased productivity, better workouts, more capacity to handle stress, enhanced cognitive performance, and an overall whole-system upgrade.Qualia Nootropic Energy Shots: The Future of EnergyWhen you are tired and low on energy, even the simplest task seems like an enormous burden. Thinking, acting, and even feeling is difficult when your energy is low. Pound for pound the brain uses the most energy of any organ. There are many energy shots, drinks, and so-called energy solutions but none are as firmly rooted in supporting the organ that needs the energy the most, your brain, than Qualia Nootropic Energy. Our shot delivers 12 high-purity nutrients to enhance your energy and brain health. Take it every day or just when you need to perform at your peak.Doctors, Scientists, Health, and Fitness Leaders Love NeurohackerOur mission and complex systems formulation approach is attracting thought leaders and researchers from leading institutions from around the world from diverse fields — psychology, neurobiology, fitness, wellness, technology, and medicine.Neurohacker Collective’s Next StepsWe look to provide people with the products, resources, and tools they need to help their whole being — mind, brain, and body — work together in harmony. Our expanding product development team comprised of doctors, neuroscientists, and chemists have identified product opportunities where we can use our unique formulation process to deliver category-defining products to the market for each category. As our company grows and the science evolves we are committed to continuing to develop best in class products to enhance human well-being.\u0026nbsp;Product RoadmapOur Customers Are Passionate About UsWe’ve developed our products with potent, high-purity, and bioavailable forms of each ingredient and our customers love that.\u0026nbsp;Qualia nootropics are used by some top personalities in the fields of science, sports, academia, and business including: Jason Silva, Mark Divine, Ben Greenfield, Jamie Wheel, Dr. H. Mcllroy, Dr. J. Becker, Dr. Hyla Cass and more.Founder InterviewsJames Schmachtenberger Chief Executive Officer of Neurohacker CollectiveJames knows the potential of cognitive optimization firsthand. Here, he explains the neurological and physiological struggles he experienced at the dawn of his ambitious career, and the life-changing event that sparked his vision for Neurohacker Collective.Daniel Schmachtenberger Chief Strategy Officer of Neurohacker CollectiveDaniel's understanding of complex systems and whole systems science is distinct from reductive science. Here, he explains the approach we are using to address humanity's most challenging issues of human capacity.Jordan Greenhall Executive Chairman of Neurohacker CollectiveJordan has led startups to enormous successes before. Here, he explains why he chose Neurohacker Collective as his next venture, and gives a detailed analysis of the success we've already had, and our collective philosophy for fundraising.","location":"Carlsbad, CA","website":"https://qualialife.com","total_amount_raised":2078571,"total_investors":1033,"is_funded":true,"is_active":true,"quality_score":3,"related_urls":["https://wefunder.com/neurohacker","https://qualialife.com"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/cover_photo_version4/15182/retina_cropped_nasa-89127-unsplash.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/cover_photo_version4/15182/standard_cropped_nasa-89127-unsplash.jpg"},"links":{"company_url":"https://qualialife.com","facebook_url":"https://facebook.com/Qualialife/","instagram_url":"https://instagram.com/qualialife/","youtube_url":"https://youtube.com/channel/UCv9hjmC-M77u3E8lUuO1-nQ","tiktok_url":"https://tiktok.com/@qualialife"},"highlights":[],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"PURPOSE: Mission driven wellness company with premium products across desirable categories."},{"index":2,"claim_id":"claim-fact-2","value":"GROWTH POTENTIAL: $578 Billion global market (2025) with 8.8% CAGR."},{"index":3,"claim_id":"claim-fact-3","value":"SCIENCE: Unique approach to science-backed product development."},{"index":4,"claim_id":"claim-fact-4","value":"TEAM: Top scientists, MD/PhD advisors, biohackers, investors and loyal customers contribute to product ideation, formulation and testing."},{"index":5,"claim_id":"claim-fact-5","value":"RECURRING REVENUES: Proven, profitable subscription model with attractive margins."},{"index":6,"claim_id":"claim-fact-6","value":"MULTI-CHANNEL SALES: Direct-to-consumer, wholesale, practitioners, and Amazon."},{"index":7,"claim_id":"claim-fact-7","value":"OPERATIONAL EXCELLENCE: Over $20M in lifetime sales; profitable in 2019 (on EBITDA basis)."}],"team":[{"id":461706,"entity_id":"wefunder:company_role:461706","user_entity_id":"wefunder:user:58344","role":"founder","name":"James Schmachtenberger","title":"CEO","bio":"Founded Mankind Cooperative; deep interest in human potential optimization.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/461706/square_cropped_james.jpg?1738948962","profile_url":"https://wefunder.com/jamesschmachtenberger","personal_url":"https://qualialife.com","linkedin_url":"https://www.linkedin.com/in/jamesschmachtenberger/","related_urls":["https://wefunder.com/jamesschmachtenberger","https://qualialife.com"]},{"id":131550,"entity_id":"wefunder:company_role:131550","user_entity_id":"wefunder:user:94052","role":"founder","name":"Jordan Greenhall","title":"Executive Chair","bio":"A serial entrepreneur who co-founded companies Swell, Inc., Game B, and DivX.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/131550/square_cropped_jordan.jpg?1724253460","profile_url":"https://wefunder.com/jordangreenhall","personal_url":"http://neurohacker.com","linkedin_url":"https://www.linkedin.com/in/jordangreenhall/","related_urls":["https://wefunder.com/jordangreenhall","http://neurohacker.com"]},{"id":245494,"entity_id":"wefunder:company_role:245494","user_entity_id":"wefunder:user:159690","role":"employee","name":"Hakan Lindskog","title":"Chief Operating Officer","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/245494/square_cropped_Hakan_Lindskog-cc44a56a-cfbe-4c83-b98a-f7f30affc619.jpg?1578963146","profile_url":"https://wefunder.com/hakanlindskog2","linkedin_url":"https://www.linkedin.com/in/hakan-lindskog-20354143/","related_urls":["https://wefunder.com/hakanlindskog2"]},{"id":278675,"entity_id":"wefunder:company_role:278675","user_entity_id":"wefunder:user:167610","role":"employee","name":"Shawn Ramer","title":"Senior Vice President, Product Development","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278675/square_cropped_Shawn_Ramer-13dc4b55-dc46-49ec-9d43-72ed6fbddbf1.jpg?1578959941","profile_url":"https://wefunder.com/shawnramer3","linkedin_url":"https://www.linkedin.com/in/shawn-ramer/","related_urls":["https://wefunder.com/shawnramer3"]},{"id":278677,"entity_id":"wefunder:company_role:278677","role":"employee","name":"Greg Kelly, ND","title":"Lead Product Formulator","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278677/square_cropped_Greg_42-e3d4460f-c0bb-49de-bcc1-7ab9b5eb7e20.jpg?1578959946","linkedin_url":"https://www.linkedin.com/in/gregory-kelly-98b96b138/","related_urls":[]},{"id":144837,"entity_id":"wefunder:company_role:144837","role":"employee","name":"Dan Stickler, M.D.","title":"Medical Director","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/144837/square_cropped_DanStickler.jpg?1578959950","linkedin_url":"https://www.linkedin.com/in/drstickler/","related_urls":[]},{"id":121072,"entity_id":"wefunder:company_role:121072","user_entity_id":"wefunder:user:104646","role":"employee","name":"Mark How","title":"Chief Revenue Officer","bio":"Entrepreneur, founder, investor, in tech startups. Also Corp Dev., BD, Sales \u0026amp; Marketing","avatar_url":"http://uploads.wefunder.com/uploads/user/avatar/104646/large_cropped_Mark_How-d71b1138-41d2-4d3f-b638-dfe91f24ecf4.jpg?1578959950","profile_url":"https://wefunder.com/markhow","personal_url":"http://neurohacker.com","linkedin_url":"https://www.linkedin.com/in/markhow","related_urls":["https://wefunder.com/markhow","http://neurohacker.com"]},{"id":277686,"entity_id":"wefunder:company_role:277686","user_entity_id":"wefunder:user:166005","role":"employee","name":"Lauren Alexander","title":"Vice President, Marketing","bio":"I am VP of Marketing for Neurohacker Collective, a company focused on making groundbreaking products for wellness. For over 12 years I have helped create winning marketing strategies for companies.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/277686/square_cropped_Lauren_Alexander-fd94ca9b-a4df-465a-b25a-b44a1bb624ad.jpg?1578959941","profile_url":"https://wefunder.com/laurenalexander2","linkedin_url":"https://www.linkedin.com/in/laurenkayalexander/","related_urls":["https://wefunder.com/laurenalexander2"]},{"id":278672,"entity_id":"wefunder:company_role:278672","role":"employee","name":"Gk Parish-Philp","title":"Vice President, Technology","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278672/square_cropped_GK_Parish_Philp-b83c8aad-1757-4067-8fba-fbaed00140a7.jpg?1578959910","linkedin_url":"https://www.linkedin.com/in/gkparishphilp/","related_urls":[]},{"id":428167,"entity_id":"wefunder:company_role:428167","user_entity_id":"wefunder:user:226497","role":"employee","name":"Ben Seeman","title":"Vice President, Wholesale Sales","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/428167/square_cropped_BSeeman.jpg?1578959905","profile_url":"https://wefunder.com/ben.seeman","linkedin_url":"https://www.linkedin.com/in/r-ben-seeman-b59213112/","related_urls":["https://wefunder.com/ben.seeman"]},{"id":144840,"entity_id":"wefunder:company_role:144840","role":"employee","name":"Sara Adaes, Ph.D.","title":"Scientific Researcher","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/144840/square_cropped_SaraAdaes.jpg?1579297955","linkedin_url":"https://www.linkedin.com/in/saradaes/?ppe=1","related_urls":[]},{"id":131570,"entity_id":"wefunder:company_role:131570","user_entity_id":"wefunder:user:104692","role":"employee","name":"Justin Schilf","title":"Creative Director","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/131570/square_cropped_Justin_Schilf-1ff432b5-db71-4043-99a0-5c5111717e73.jpg?1579297955","profile_url":"https://wefunder.com/justinschilf","linkedin_url":"https://www.linkedin.com/in/justinschilf/","related_urls":["https://wefunder.com/justinschilf"]},{"id":278678,"entity_id":"wefunder:company_role:278678","role":"employee","name":"Ben Cote","title":"Director of Community","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278678/square_cropped_Ben_Cote-5f01c909-bef7-4f08-8105-36a215d7a108.jpg?1579297953","linkedin_url":"https://www.linkedin.com/in/bencote/","related_urls":[]},{"id":129427,"entity_id":"wefunder:company_role:129427","role":"employee","name":"Jodi Geigle","title":"Community Experience Manager","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/129427/square_cropped_Jodi_Hettinga-bc9a344e-138e-44ec-b7a9-aecbfd943fdf.jpg?1579297949","linkedin_url":"https://www.linkedin.com/in/jodigeigle/","related_urls":[]},{"id":289555,"entity_id":"wefunder:company_role:289555","role":"employee","name":"Jennifer Norton","title":"Production Manager","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/289555/square_cropped_square_cropped_Jennifer_Gold-6f5e1e40-3f6d-44f1-8850-1aad8c4e7efe.jpg?1579297947","linkedin_url":"https://www.linkedin.com/in/jennifer-gold-b74984140/","related_urls":[]},{"id":130690,"entity_id":"wefunder:company_role:130690","role":"employee","name":"Darrell Grable","title":"Director Partner Sales","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/130690/square_cropped_darrell.jpg?1579297942","linkedin_url":"https://www.linkedin.com/in/darrell-grable-915b48135/","related_urls":[]},{"id":278681,"entity_id":"wefunder:company_role:278681","role":"employee","name":"Michael Ferguson","title":"Senior Data Analytics Engineer","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278681/square_cropped_mike2-3daf5b33-3caa-49d7-932c-4c44f5b559be-96e0b24e-df6f-4771-bdc6-35fafe5c2ced.jpg?1579297938","linkedin_url":"https://www.linkedin.com/in/michael-glen-ferguson/","related_urls":[]},{"id":428303,"entity_id":"wefunder:company_role:428303","role":"employee","name":"Chase Imbert","title":"Partnership Manager","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/428303/square_cropped_Chase.jpg?1579297929","linkedin_url":"https://www.linkedin.com/in/chase-imbert-821201139/","related_urls":[]},{"id":129425,"entity_id":"wefunder:company_role:129425","user_entity_id":"wefunder:user:107420","role":"employee","name":"Jacquelyn Loera","title":"Podcast Producer","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/129425/square_cropped_Jacquelyn_Loera-dcdbdbe9-229a-4d68-9f80-7e66160c8e22.jpg?1579297925","profile_url":"https://wefunder.com/jacquelynloera","personal_url":"http://neurohacker.com","linkedin_url":"https://www.linkedin.com/in/jacquelynloera","related_urls":["https://wefunder.com/jacquelynloera","http://neurohacker.com"]},{"id":278679,"entity_id":"wefunder:company_role:278679","role":"employee","name":"Abhi Ardagh","title":"Marketing Coordinator","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/278679/square_cropped_Abhi_Ardagh-fb67c8ed-449c-4c6c-af6f-9ed7b4ba1309.jpg?1579297915","linkedin_url":"https://www.linkedin.com/in/abhiardagh/","related_urls":[]},{"id":103659,"entity_id":"wefunder:company_role:103659","user_entity_id":"wefunder:user:94366","role":"employee","name":"Angie Buchholz","title":"People Operations","bio":"Human Resources \u0026amp; Executive Assistant to COO Hakan Lindskog of Neurohacker Collective","avatar_url":"http://uploads.wefunder.com/uploads/user/avatar/94366/large_cropped_Angela_Buchholz-0386df2e-3f2f-4644-bdf5-4d06d05df4bb.jpg?1579297915","profile_url":"https://wefunder.com/angiebuchholz","personal_url":"http://neurohacker.com","linkedin_url":"https://www.linkedin.com/in/angelabuchholz","related_urls":["https://wefunder.com/angiebuchholz","http://neurohacker.com"]},{"id":289547,"entity_id":"wefunder:company_role:289547","role":"employee","name":"Cassandra Brooks","title":"Executive Assistant","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/289547/square_cropped_large_cropped_Cassandra_Brooks-1a911993-20d1-4754-8876-96f1d0cf46a6.jpg?1579297909","linkedin_url":"http://www.linkedin.com/in/cassandra-brooks-89b506ab/https://www.linkedin.com/in/cassandra-brooks-89b506ab/","related_urls":[]},{"id":819532,"entity_id":"wefunder:company_role:819532","user_entity_id":"wefunder:user:476555","role":"employee","name":"Clark Weigand","title":"Controller","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/819532/square_cropped_clark.jpg?1579641168","profile_url":"https://wefunder.com/clark.weigand","related_urls":["https://wefunder.com/clark.weigand"]},{"id":819533,"entity_id":"wefunder:company_role:819533","user_entity_id":"wefunder:user:451511","role":"employee","name":"Kiki WILLIAMS","title":"Customer Support Agent","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/819533/square_cropped_kiki.jpg?1579116459","profile_url":"https://wefunder.com/kiki.williams","related_urls":["https://wefunder.com/kiki.williams"]}],"featured_investors":[],"investor_memos":[],"tab_counts":{"posts":30,"ask_questions":160,"featured_investors":0,"faq_entries":5},"active_fundraises":[{"id":29942,"entity_id":"wefunder:fundraise:29942","state":"successful","offering_type":"506(c)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":250000.0,"funding_started_at":"2020-04-15T23:46:53Z","funding_closed_at":"2020-04-15T23:46:53Z"},{"id":29172,"entity_id":"wefunder:fundraise:29172","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":500,"max_purchase":9,"funding_target":100000.0,"funding_started_at":"2020-01-18T02:33:56Z","funding_closed_at":"2020-03-14T05:01:51Z","auto_close_at":"2020-03-14T03:59:59Z"},{"id":24404,"entity_id":"wefunder:fundraise:24404","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":500,"max_purchase":9,"funding_target":100000.0,"funding_started_at":"2019-03-25T15:46:13Z","funding_closed_at":"2019-05-31T04:01:49Z","auto_close_at":"2019-05-31T03:59:59Z"},{"id":20558,"entity_id":"wefunder:fundraise:20558","state":"successful","offering_type":"506(c)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":250000.0,"funding_started_at":"2018-08-28T02:23:10Z","funding_closed_at":"2018-08-28T02:23:10Z"},{"id":18654,"entity_id":"wefunder:fundraise:18654","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":500,"max_purchase":9,"funding_target":100000.0,"funding_started_at":"2018-07-12T21:47:29Z","funding_closed_at":"2018-08-25T04:02:05Z","auto_close_at":"2018-08-25T03:59:59Z"},{"id":10601,"entity_id":"wefunder:fundraise:10601","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":500,"max_purchase":9,"funding_target":250000.0,"funding_started_at":"2017-06-21T00:20:56Z","funding_closed_at":"2017-11-21T00:00:00Z","auto_close_at":"2017-11-22T04:59:59Z"}],"latest_fundraise":{"id":29942,"entity_id":"wefunder:fundraise:29942","state":"successful","offering_type":"506(c)","structure":"safe","testing_the_waters":false,"can_invest_now":false,"funding_started_at":"2020-04-15T23:46:53Z","funding_closed_at":"2020-04-15T23:46:53Z","terms":{"eb":null,"nb":"$65M","txt":"valuation cap"}},"recent_posts":[{"id":131198,"entity_id":"wefunder:feed_item:131198","type":"FeedItem::Update","visibility":"public","title":"You Have Less Than 48 Hours Left To Own Equity In Neurohacker Collective, And We Have An Exciting Announcement For Why You Should!","preview":"Since our inception, Neurohacker Collective has sought to offer groundbreaking products in some of the most challenging realms of neurophysiology. Thanks to your funding this round, we’re now able to greenlight a formula we’ve been working on for well over a year, intended to be unlike anything else offered for the struggle it addresses. Sleep. If you struggle with it, you’re not alone. Did you know roughly 25% of Americans report insufficient sleep at least half their nights? And poor sleep ...","published_at":"2020-03-12T10:01:34Z","author_name":"James Schmachtenberger","url":"/feed/131198","canonical_url":"https://wefunder.com/feed/131198"},{"id":130740,"entity_id":"wefunder:feed_item:130740","type":"FeedItem::Update","visibility":"public","title":"It’s Our Campaign’s Final Few Days, And A Lot Hangs In The Balance. Let Us Explain Why.","preview":"If you are a current investor, or a last-minute addition to our community of investors, we wanted to explain to you how vital the remaining portion of funding is to secure our future growth potential (and the growth potential of your equity in us). In this round, we’re using the first 100,000 dollars we’ve already secured, for the release of a sleep optimization product. This product will be designed to optimize the neuroregulatory conditions that allow healthy sleep cycles, rather than merel...","published_at":"2020-03-11T03:27:49Z","author_name":"James Schmachtenberger","url":"/feed/130740","canonical_url":"https://wefunder.com/feed/130740"},{"id":130739,"entity_id":"wefunder:feed_item:130739","type":"FeedItem::Update","visibility":"public","title":"The Final Days Of Our Nearly 2 Million Dollar Wefunder Campaign Are Here! Invest Now For Your Last Chance To Own Equity In Neurohacker!","preview":"This announcement is both exciting and bittersweet to make.Your help has given us the amazing ability to deliver on our mission. We’re now well-positioned to offer breakthrough well being products to a huge global community.And so many of you are now included in the word “our”. We’re humbled and honored that our campaign has become one of the most successful in Wefunder history, with nearly 2 million dollars invested in us. But it’s the grassroots nature of those investments that have meant t...","published_at":"2020-03-03T16:14:17Z","author_name":"James Schmachtenberger","url":"/feed/130739","canonical_url":"https://wefunder.com/feed/130739"},{"id":129718,"entity_id":"wefunder:feed_item:129718","type":"FeedItem::Update","visibility":"public","title":"Your Funding Has Enabled One Of The Best Educational Podcasts On The Planet!","preview":"At Neurohacker Collective, the wellness of our community is about more than our nutritional products. It is also about fostering our community’s education on the body, mind, relationships, and environment that form the human experience. That is why we launched our podcast Collective Insights in October of 2017, to engage some of the most brilliant minds in the world on the topics and technologies revolutionizing human well being. Collective Insights is a unique format in podcasting, with a di...","published_at":"2020-02-24T19:27:56Z","author_name":"James Schmachtenberger","url":"/feed/129718","canonical_url":"https://wefunder.com/feed/129718"},{"id":129095,"entity_id":"wefunder:feed_item:129095","type":"FeedItem::Update","visibility":"public","title":"Big Retail Announcement: Major Stores \u0026amp; Wellness Sites Now Carrying Our Products!","preview":"A little over a year ago, Neurohacker brought on 20-year industry veteran Ben Seeman as our VP of Wholesale, tasked with getting Neurohacker products through the application gauntlet of major stores and wellness sites, to legitimize our brand to a mainstream audience.We couldn’t be happier to tell you where his wholesale leadership has taken us: Regarding making it into major brick and mortar stores, Neurohacker has recently secured our spot on the shelves of California’s most trendsetting he...","published_at":"2020-02-17T13:22:43Z","author_name":"James Schmachtenberger","url":"/feed/129095","canonical_url":"https://wefunder.com/feed/129095"},{"id":129094,"entity_id":"wefunder:feed_item:129094","type":"FeedItem::Update","visibility":"public","title":"We're Nearing Wefunder Records With Almost 2 MILLION Raised! This Product Roadmap Explains Investor Excitement!","preview":"For an investor, there’s something even better than a company with a great product. The best scenario, is a company with a unique approach enabling many great products, which can disrupt an entire industry.As the pioneers of whole-systems modeling for nutritional formulations, we can create product offers in domain after domain of health challenges which comprehensively address health dysfunctions at the level of cause rather than symptoms.The Wefunder audience has noticed the rare growth pot...","published_at":"2020-02-10T23:28:30Z","author_name":"James Schmachtenberger","url":"/feed/129094","canonical_url":"https://wefunder.com/feed/129094"},{"id":128461,"entity_id":"wefunder:feed_item:128461","type":"FeedItem::Update","visibility":"public","title":"This Is My Personal Health Crisis That Led To Neurohacker Collective.","preview":"Most people want to leave the world a better place than they found it.I want to share with you my personal health journey that has taken Neurohacker to this moment. In my 20’s, I was an ambitious entrepreneur in my first major leadership role. I was running a small integrative health college in San Diego, and I badly wanted to demonstrate I could handle the challenge despite my young age. This led to me working 18 to 20 hour days on a routine basis. The school was doing great, but after years...","published_at":"2020-02-04T03:34:52Z","author_name":"James Schmachtenberger","url":"/feed/128461","canonical_url":"https://wefunder.com/feed/128461"},{"id":128277,"entity_id":"wefunder:feed_item:128277","type":"FeedItem::Update","visibility":"public","title":"Clinical Trial News \u0026amp; How To Help Us Show The World What Our Products Can Do!","preview":"“Right away with Qualia Mind, I noticed an increase in my mental energy and focus.” “As a small business owner, Qualia Mind has doubled my productivity. It’s a game-changer for my career!” “Eternus is amazing. I actually WANT to be active again! It’s not a chore anymore.” These are actual quotes from our customers about our products. We’re flooded with them on testimonial pages, in emails, on phone calls, and face-to-face at events where we get to meet our community. Our unique approach to nu...","published_at":"2020-01-28T19:30:10Z","author_name":"James Schmachtenberger","url":"/feed/128277","canonical_url":"https://wefunder.com/feed/128277"},{"id":128145,"entity_id":"wefunder:feed_item:128145","type":"FeedItem::Update","visibility":"public","title":"Look What Your Funding Did! Then Take Advantage Of Our Final Public Round!","preview":"“Ask yourself what makes you come alive, and go do it. Because what the world needs is people who have come alive.”- Howard ThurmanIf you worked here\u0026nbsp;at Neurohacker Collective, you would never forget some of the conversations with our customers.We interact with\u0026nbsp;customers who are often overjoyed, and sometimes even in tears because they are able to pursue their dreams again for the first time in years or decades. That’s because we’re solving problems that the traditional health and w...","published_at":"2020-01-21T01:13:14Z","author_name":"James Schmachtenberger","url":"/feed/128145","canonical_url":"https://wefunder.com/feed/128145"},{"id":118159,"entity_id":"wefunder:feed_item:118159","type":"FeedItem::Update","visibility":"public","title":"With Less Than 2 Days Left, Consider Joining Our Mission.","preview":"As Neurohacker wraps up our campaign with just a couple days to go, we wanted to explain some of the momentum behind a near-record total of over 1.4 million dollars raised on this platform. As investors on Wefunder, you can only see some of the feedback we’ve been getting. What you can’t see, is a lot of the dialogue we’ve had with investors who were motivated by their firsthand experience of our products. When a customer tells us that they’re able to show up with more vigor and energy for th...","published_at":"2019-05-29T22:09:02Z","author_name":"James Schmachtenberger","url":"/feed/118159","canonical_url":"https://wefunder.com/feed/118159"},{"id":117898,"entity_id":"wefunder:feed_item:117898","type":"FeedItem::Update","visibility":"public","title":"LAST CALL For Investment! And A Preview Of Our Product Roadmap!","preview":"If you cut your arm, and you are given an anesthetic, you may not notice the pain of the cut anymore, but you have not resolved the problem. You have merely introduced a substance to your body that overrides your ability to notice the problem. Keep that analogy in mind as a frame of reference for the unique value in Neurohacker Collective in the health and wellness space, expressed in this update.In the final days of this funding campaign, we want to draw your attention to what sets us apart,...","published_at":"2019-05-28T19:07:42Z","author_name":"James Schmachtenberger","url":"/feed/117898","canonical_url":"https://wefunder.com/feed/117898"},{"id":116642,"entity_id":"wefunder:feed_item:116642","type":"FeedItem::Update","visibility":"public","title":"Investment Round Is CLOSING! Hurry If You Want A Stake In Neurohacker!","preview":"If you’ve been considering an investment in Neurohacker, time is now of the essence as we are closing this funding round in less than 10 days. But first, please consider the evidence demonstrating the power of your investment in our hands…When Neurohacker sought our first WeFunder investors about a year and a half ago, we were a company with 1 product, available in 1 country, for purchase only through 1 website, and we were still far from profitable.We were hoping this community could give us...","published_at":"2019-05-20T18:54:12Z","author_name":"James Schmachtenberger","url":"/feed/116642","canonical_url":"https://wefunder.com/feed/116642"},{"id":116046,"entity_id":"wefunder:feed_item:116046","type":"FeedItem::Update","visibility":"public","title":"Neurohacker Launches Premium Energy Shot This Autumn After Strong Survey Results","preview":"If you haven’t followed the recent Neurohacker updates, you have missed a rapid succession of major, positive announcements:\u0026nbsp;- The launch of Eternus, our comprehensive aging formula, with sales results that blew\u0026nbsp; \u0026nbsp; away our internal forecasting to the point of an impending backorder for the product.- The expansion of our e-commerce presence to Walmart.com, America’s 3rd largest e- commerce site, which adds to over a million in annual revenue already coming in\u0026nbsp; through Amaz...","published_at":"2019-05-14T08:08:31Z","author_name":"James Schmachtenberger","url":"/feed/116046","canonical_url":"https://wefunder.com/feed/116046"},{"id":115902,"entity_id":"wefunder:feed_item:115902","type":"FeedItem::Update","visibility":"public","title":"Investor Update Q1 2019","preview":"Dear Investors, Friends and Stakeholders,In many ways, Q1 of this year felt like a springboard for what’s to come. Some exciting things came to fruition during the quarter but the most interesting and exciting parts of the quarter are what we were able to put in place for Q2 and beyond.Most notably, we focused our energy during Q1 on being able to expand our product footprint outside of the cognitive domain and into multiple other aspects of health, with an initial focus on longevity.During t...","published_at":"2019-05-10T23:06:04Z","author_name":"James Schmachtenberger","url":"/feed/115902","canonical_url":"https://wefunder.com/feed/115902"},{"id":115443,"entity_id":"wefunder:feed_item:115443","type":"FeedItem::Update","visibility":"public","title":"Neurohacker Launches Product Lineup On Walmart.com","preview":"It’s well known that amazon.com is America’s largest e-commerce site.What’s lesser known is that walmart.com now ranks 3rd, with nearly $21 billion in online sales for 2018. Walmart’s online sales are growing rapidly, with some projections- such as by emarketer.com- forecasting Walmart’s online sales to grow at almost 40% for 2019. With over a million in revenue coming in through our amazon.com sales, we’re excited to expand our e-commerce presence to one of the other major players in the spa...","published_at":"2019-05-07T01:19:42Z","author_name":"James Schmachtenberger","url":"/feed/115443","canonical_url":"https://wefunder.com/feed/115443"},{"id":115173,"entity_id":"wefunder:feed_item:115173","type":"FeedItem::Update","visibility":"public","title":"Major New Partnership Announcement From Neurohacker Collective!","preview":"The field of naturopathic medicine is exploding in popularity, and if you’re an investor in Neurohacker Collective, you will be excited to hear this announcement, because we just finalized a new partnership that will give our organization a high profile with tens of thousands of naturopaths, and their patients, for a long time to come.Firstly, the facts; according to the Bureau of Labor Statistics, naturopathic medicine added 24,000 jobs last year, and the employment field as a whole is trend...","published_at":"2019-05-02T21:50:59Z","author_name":"James Schmachtenberger","url":"/feed/115173","canonical_url":"https://wefunder.com/feed/115173"},{"id":114567,"entity_id":"wefunder:feed_item:114567","type":"FeedItem::Update","visibility":"public","title":"Look At What Your Support Just Did!","preview":"What happened this past week is incredibly powerful to us. In a sense, it marks the end of us ambitioning to be a full fledged\u0026nbsp;bioscience organization, and the beginning of us truly being one.Let me share the news...Last Tuesday, we launched our new product Eternus. After extensive research, we knew we’d created the most advanced product available for slowing the negative effects of aging. We accomplished this by addressing aging where it begins- at the cellular level- with a 38 ingredie...","published_at":"2019-04-25T22:09:01Z","author_name":"James Schmachtenberger","url":"/feed/114567","canonical_url":"https://wefunder.com/feed/114567"},{"id":113112,"entity_id":"wefunder:feed_item:113112","type":"FeedItem::Update","visibility":"public","title":"The Moment Has Arrived! Get Ready For Our Biggest Announcement IN TWO YEARS!","preview":"Today, April 16th, 2019 is one of the most exciting days in the history of our company.If you’re an investor or considering becoming one, you’re going to want to read the news we’re about to share. Hint: read this all the way through, because towards the end, it includes a limited time offer that we think you’ll appreciate. But first...Imagine you had to come up with a checklist of characteristics for the most successful wellness product possible. What would the checklist\u0026nbsp;look like? We b...","published_at":"2019-04-16T18:08:12Z","author_name":"James Schmachtenberger","url":"/feed/113112","canonical_url":"https://wefunder.com/feed/113112"},{"id":110327,"entity_id":"wefunder:feed_item:110327","type":"FeedItem::Update","visibility":"public","title":"Set Business Aside: This Is The Human Story That Created Neurohacker Collective.","preview":"Where does the inspiration for a business begin? Before business metric updates- before a company even has a mission statement- what is the moment that a citizen is compelled to action in the world towards something they care about? That is what this update is about; the human experiences that inspired Neurohacker Collective into being. This update will be longer than most, because this isn't so much\u0026nbsp;a company update as it is an earnest\u0026nbsp;background as to what formed the growing compa...","published_at":"2019-04-10T01:00:11Z","author_name":"James Schmachtenberger","url":"/feed/110327","canonical_url":"https://wefunder.com/feed/110327"},{"id":107225,"entity_id":"wefunder:feed_item:107225","type":"FeedItem::Update","visibility":"public","title":"Evidence Makes A \"Mission\" Real. Here's Ours.","preview":"If a company’s mission attracts you, that is great, but that alone is not a reason to invest in it.A company also needs to supply clear evidence that it is growing, stable, and capable of achieving that mission.Otherwise, neither their mission, nor your financial return on investment, will ever occur. So instead of talking about our future plans as we did in our last update, we want to use this update to expound on our growth since our WeFunder campaign last year. We respect every hard earned...","published_at":"2019-04-02T23:28:52Z","author_name":"James Schmachtenberger","url":"/feed/107225","canonical_url":"https://wefunder.com/feed/107225"},{"id":95866,"entity_id":"wefunder:feed_item:95866","type":"FeedItem::Update","visibility":"public","title":"You've Fueled Our Rise. Invest Now In Our Global Growth Phase!","preview":"When Neurohacker Collective was founded back in 2015, we set out on a mission to radically upgrade mental and physical wellbeing with the most comprehensive approach possible. This meant using complex systems science (rather than reduction science) to formulate groundbreaking products for mind and body. It also meant assembling some of the most innovative minds in biochemistry on our science and medical team. But it goes further than products. We want to uplevel people’s understanding of how ...","published_at":"2019-03-28T17:59:15Z","author_name":"James Schmachtenberger","url":"/feed/95866","canonical_url":"https://wefunder.com/feed/95866"},{"id":93644,"entity_id":"wefunder:feed_item:93644","type":"FeedItem::Update","visibility":"public","title":"A Final Update On What You Have Meant To Us.","preview":"With just 1 day left in our campaign, we wanted to meaningfully reflect on the extraordinary position we now find ourselves in, due in large measure from Wefunder\u0026nbsp;investors inspired to fund our\u0026nbsp;vision.\u0026nbsp; With our max target reached this round of 261k\u0026nbsp;joining over 800k raised in our prior Wefunder round, we join just a handful of Wefunder campaigns to raise over a million dollars on this platform. And we've read every comment and every message you've sent us as to your why f...","published_at":"2018-08-24T01:14:24Z","author_name":"James Schmachtenberger","url":"/feed/93644","canonical_url":"https://wefunder.com/feed/93644"},{"id":93569,"entity_id":"wefunder:feed_item:93569","type":"FeedItem::Update","visibility":"public","title":"Introducing Qualia Focus: An Affordable Premium Nootropic Product.","preview":"Neurohacker Collective’s strategy in the nootropics market has been as follows: 1st, we wanted to demonstrate our formulations work. We realized, above all, a product company has to deliver on intended results to last. We achieved this with our original nootropic product simply called Qualia. With the revenue generated from the sales of our original product, we went back to the lab to formulate a product with a more difficult 2nd goal: we wanted to create a formulation that is easy to use and...","published_at":"2018-08-22T23:22:47Z","author_name":"James Schmachtenberger","url":"/feed/93569","canonical_url":"https://wefunder.com/feed/93569"},{"id":93237,"entity_id":"wefunder:feed_item:93237","type":"FeedItem::Update","visibility":"public","title":"Q2 Results Are In, And We Think You'll Like What You See.","preview":"Hi Everyone,Q2 was a strong a quarter for us with some exciting milestones accomplished. Most notably, we achieved one of the biggest milestones that startups strive for. In June we achieved profitability for the first time!\u0026nbsp;It’s OK if you want to pause now and do a happy dance before reading further, all of the Neurohacker team did when they first heard the news :) We spent a large portion of the quarter, de-emphasizing the focus on top line growth and prioritizing a focus on profitabil...","published_at":"2018-08-16T19:21:09Z","author_name":"James Schmachtenberger","url":"/feed/93237","canonical_url":"https://wefunder.com/feed/93237"},{"id":93006,"entity_id":"wefunder:feed_item:93006","type":"FeedItem::Update","visibility":"public","title":"We've Hit Our Posted Max Goal, But You Can Still Invest For A Short Time. Here's Why...","preview":"Neurohacker Collective has now achieved our maximum goal of $261k. If you still wish to make a significant investment, you can, but we wanted to take a moment to explain what happens now depending on your investor status. Now that Neurohacker Collective has reached its goal of 261k, we are setting up a Regulation D campaign. This will allow those of you who are accredited investors to continue large investments without concern for the listed 261k cap, as your investments may be transferred fr...","published_at":"2018-08-13T17:55:22Z","author_name":"James Schmachtenberger","url":"/feed/93006","canonical_url":"https://wefunder.com/feed/93006"}],"q_and_a":[{"id":289430,"entity_id":"wefunder:comment:289430","question":"Could you provide an update on when I might start seeing returns on investment?","author_name":"Faryal Ijaz","votes":4,"created_at":"2024-08-03T21:22:42Z","canonical_url":"https://wefunder.com/neurohacker#question-289430","answers":[]},{"id":57384,"entity_id":"wefunder:comment:57384","question":"How do I redeem my investment perk?","author_name":"Mitch Walsh","votes":3,"created_at":"2019-07-18T00:40:58Z","canonical_url":"https://wefunder.com/neurohacker#question-57384","answers":[{"id":57882,"entity_id":"wefunder:comment:57882","answer":"Hi Mitch. You should have received a message from us already about your perks. If you didn't get that please send an email to support@neurohacker.com. Thank you!","author_name":"James Schmachtenberger","votes":0,"created_at":"2019-07-25T18:59:08Z"}]},{"id":33014,"entity_id":"wefunder:comment:33014","question":"Hi, I'd would love to invest in NC! Am I too late? Can you please clarify all the following: 1) Length, dates \u0026amp; conditions of next investment round. 2) Would I become a shareholder if I invest? 3) Are there any limitation on investing from outside the US? 4) Min/max sums to invest. 5) What are the financial plans for the future? 6) Are you planning to become public/go to the stock exchange? 7) What exactly are the POINTS investors get? 8) What exactly is SAFE note you referred to in other question below? 9) Are you planning to ship to Israel? 10) I cannot see an \"Invest\" button, why? 11) How exactly is the dividends return planned to work out? 12) Very important: Why wouldn't any another company just copy your formulas if they are out there for all to see? What protects that? Please elaborate as much as you can on all these questions, as simply as possible. Many thanks! Ben","author_name":"Ben JC","votes":3,"created_at":"2019-01-09T15:13:50Z","canonical_url":"https://wefunder.com/neurohacker#question-33014","answers":[]},{"id":10481,"entity_id":"wefunder:comment:10481","question":"I'm not a fan of SAFE agreements for non-tech start-ups. Here's an excerpt from your Form C explaining just some of the concern: \"...In certain circumstances, such as the sale of the company, an initial public offering or dissolution or bankruptcy, holders may only have a right to receive cash to the extent available, rather than preferred stock or other securities. In addition, if the SAFEs are so converted, the holders will lose any rights and preferences of the SAFEs that are not included in the terms of our preferred stock.We are under no obligation to convert the SAFEs into preferred stock. We may never receive a future equity financing or experience a liquidity event, in which case, the holders could be left holding the SAFEs indefinitely. Unlike convertible notes and other securities convertible into or exchangeable for preferred stock, the SAFEs do not have any “default” provisions permitting the holders to demand repayment. We have the discretion as to whether or not to enter into a transaction that causes the conversion of the SAFEs into preferred stock, and the holders have no right to demand such a conversion....\". Offering stock, a Convertible Note or Units in an LLC would be much more attractive from an investor point of view. Wish you all the luck in a very tough industry. Let me know if you decide to modify your offering please!","author_name":"Barnaby Zelman","votes":3,"created_at":"2017-06-21T07:32:39Z","canonical_url":"https://wefunder.com/neurohacker#question-10481","answers":[]},{"id":260506,"entity_id":"wefunder:comment:260506","question":"Hi James. I invested in the 2017 round because I worked with Jordan, Mark (How), GK and Ben at DivX. Is there somewhere where you have discussed your exit strategy or, if not, can you tell us what you are building towards in terms of investor returns / exit?","author_name":"Brad Sorensen","votes":1,"created_at":"2023-08-29T10:13:04Z","canonical_url":"https://wefunder.com/neurohacker#question-260506","answers":[{"id":260854,"entity_id":"wefunder:comment:260854","answer":"Brad, Thank you for your question. Currently we are focused on building shareholder value by growing revenues and profitability. We are not actively considering an exit. However, given our current elevated growth rate (22% in Q2!), we anticipate that Neurohacker will become an attractive acquisition target for strategic investors in the next 2-5 years. Depending on capital needs and market conditions, a public offering could be another option. As always, although prospects are bright at this point, there are no guarantees that we can execute a successful exit. Thank you for your support, Brad!","author_name":"James Schmachtenberger","votes":0,"created_at":"2023-08-31T14:37:22Z"}]},{"id":254802,"entity_id":"wefunder:comment:254802","question":"Hello! It's been quite some time since there have been any updates on this page. As an investor, I'm eager to know what the Company's next steps are and your plans concerning the IPO. Thank you!","author_name":"Faryal Ijaz","votes":1,"created_at":"2023-07-19T17:39:09Z","canonical_url":"https://wefunder.com/neurohacker#question-254802","answers":[{"id":275733,"entity_id":"wefunder:comment:275733","answer":"Hello, Faryal; I apologize for the delayed response. We recently saw your question when posting an update on the platform today! Thank you for your question! We post quarterly updates to our investors here on the Wefunder platform. The most recent one was posted today. It offers a comprehensive review of our results, major developments, and future plans. As for an IPO or other liquidity event, we have no firm plans at this point. For the time being, we are focused on building shareholder value to maximize the outcome in a future liquidity event. If you have further questions after reading our Q4 update, please let us know. Thank you for your interest!","author_name":"James Schmachtenberger","votes":0,"created_at":"2024-02-08T01:03:38Z"}]},{"id":216101,"entity_id":"wefunder:comment:216101","question":"Is there any fund raising round in coming future?","author_name":"Roshan Joshi","votes":1,"created_at":"2022-08-22T00:18:26Z","canonical_url":"https://wefunder.com/neurohacker#question-216101","answers":[{"id":216589,"entity_id":"wefunder:comment:216589","answer":"Hi Roshan. Thank you for reaching out! At the moment, the company is in a strong enough financial position to fund its upcoming growth initiatives so we're not planning for another funding round soon. However, there are some large growth initiatives we're working on and if they come to fruition they'll likely require additional capital to execute so that could speed up our next funding round. Thank you","author_name":"James Schmachtenberger","votes":0,"created_at":"2022-08-26T21:39:22Z"}]},{"id":78738,"entity_id":"wefunder:comment:78738","question":"I am interested in investing in Qualia Company, I just don’t full understand the perks once invested. What do I get for my money? Thanks.","author_name":"Dr. Michael Rubenstein","votes":1,"created_at":"2020-02-17T01:34:25Z","canonical_url":"https://wefunder.com/neurohacker#question-78738","answers":[{"id":80091,"entity_id":"wefunder:comment:80091","answer":"Hi Michael. Thank you for your interest in investing! When you invest in us through WeFunder you will receive equity in the form of a SAFE Note. Once we raise a fixed-price funding round, that will cause the equity (SAFE notes) of the WeFunder investors to convert into preferred units of our company. From there you'll be eligible to participate in any profit distributions if we issue them and will be able to participate in the upside from the potential exit of the company. In addition to owning a piece of the company, we also provide additional perks for investing. These perks depend on the amount you invest and are mostly oriented around receiving free product. If you invest $500 you get a free bottle of the product of your choice. With higher amounts you get a subscription, etc.","author_name":"James Schmachtenberger","votes":3,"created_at":"2020-02-26T00:12:48Z"}]},{"id":78721,"entity_id":"wefunder:comment:78721","question":"Your product packaging is incredible, but it feels wasteful. I really like Daniels take on systems thinking and the circular materials economy, so I was wondering what steps your company will take towards zero waste?","author_name":"Paul Byrne","votes":1,"created_at":"2020-02-16T18:49:50Z","canonical_url":"https://wefunder.com/neurohacker#question-78721","answers":[{"id":80089,"entity_id":"wefunder:comment:80089","answer":"Hi Paul. This is a great question! My goal is for Neurohacker to become a company with zero waste. Unfortunately there are a number of factors related to supply chain that make that very difficult to accomplish until we have more scale. When we started the company we did an assessment on whether using plastic or glass bottles was better for the environment. I had expected the answer to be glass but by the time we factored in the additional plastic needed to bubble wrap the glass, the additional fuel usage for shipping due to increased weight, etc. it turned out that plastic was the more environmentally friendly choice. We're currently working with our packaging suppliers to explore options around bio-plastics. So far we haven't found anyone who's making the types of bottles we need in a bio-plastic but we're looking into the potential of custom production runs that would allow us to accomplish this. We're currently in a process of reviewing our packaging from both a design and materials stand point and trying to see what improvements we can make. We're still not large enough as a company for some of the things that I'd like us to do but it looks like we're probably large enough to start getting much of our packaging materials through more eco-friendly methods.","author_name":"James Schmachtenberger","votes":0,"created_at":"2020-02-26T00:09:14Z"}]},{"id":77714,"entity_id":"wefunder:comment:77714","question":"James, there were several questions regarding proposed ROI. With any IPO I have enetred, there was some proposed return, even if speculative. The belief in the product is one thing, ROI is another. If this was answered rpior, please forgive me. Steve","author_name":"Steve Harris","votes":1,"created_at":"2020-02-09T17:27:35Z","canonical_url":"https://wefunder.com/neurohacker#question-77714","answers":[{"id":80086,"entity_id":"wefunder:comment:80086","answer":"Hi Steve. Thank you for your question. The question of ROI is a very difficult one to answer since there's still a lot that's unknown about our growth path. We know clearly that we're growing at a healthy rate year over year but we haven't yet determined what our exit plan is. We may very well IPO at some point but it's also just as likely that we'd be acquired and never go public. Investing in a company pre-IPO it's a bit easier to determine likely ROI since there's usually already been an established price set for the IPO so you can assess the difference of the amount you're investing at vs the anticipated IPO price. We're not entertaining the idea of an IPO at this phase. Though it could very well make sense, it almost definitely wouldn't until we're substantially larger since there's a lot of ongoing expenses associated with going public. When investing through WeFunder you're banking on the idea that the company's value will go up (hopefully substantially) from the value at which you invested and you'll get to participate in all of that upside. I wish I could give a more exact answer but legally we're limited around making commitments on what an anticipated ROI will look like.","author_name":"James Schmachtenberger","votes":0,"created_at":"2020-02-26T00:04:00Z"}]},{"id":76054,"entity_id":"wefunder:comment:76054","question":"I invested early on in company, 1000.00. Not sure where that stands. Being a sleep medicine specialist, with connections with the sleep depot at UCD Medical School in Sacramento, as well as Northstate Medical, I have some input with a large network of innovative physicians . Curious about the sleep products, I understand the mechanics of sleep and lecture to dentists and physicians. Always looking for innovation. Big question, where is my 1k parked? In Warrants?? Fine if so. I just never see investment info until fundraising rounds. Great promise. Touch base. Tim, Mickiewicz, D.D.S.","author_name":"Tim Mickiewicz","votes":1,"created_at":"2020-01-29T04:25:10Z","canonical_url":"https://wefunder.com/neurohacker#question-76054","answers":[{"id":80085,"entity_id":"wefunder:comment:80085","answer":"Hi Tim. Thank you for your previous investment! We send quarterly investor updates to all of our investors in addition to the updates we do through the WeFunder platform. If you haven't been receiving them there may be something wrong with the email we have on file for you. You can email support@neurohacker.com and we can look into that for you. We haven't converted any of the WeFunder investments into equity yet so your investment should still be listed on the cap table as a convertible note until we reach our conversion triggers. As far as sleep products go, we're hopefully getting close to bringing our first product to market. We're taking a very different approach than is typical with the development of this product. Rather than focusing on sedation, we're focusing on providing the nutrients needed for optimizing sleep performance and supporting maximum recovery during sleep. We've done some initial testing with one of our Beta groups and got very positive results. We're currently in the middle of a larger test to confirm results and will be making decisions soon on whether the product is ready for market or if additional research is needed. I'll let our science team know about your involvement with the Universities. Maybe there's the ability to explore a study through one of the universities.","author_name":"James Schmachtenberger","votes":0,"created_at":"2020-02-25T23:59:08Z"}]},{"id":74869,"entity_id":"wefunder:comment:74869","question":"Hello James, I am a current investor and received the email notification regarding this final round. Plainly speaking, what is the company’s exit strategy? How long will you remain private? And what is the timeline? Like all investors I am anxious to receive a healthy ROI. These questions will help me to determine how much I will further invest in this final round. Thank you.","author_name":"Sparkle Williams","votes":1,"created_at":"2020-01-21T07:54:38Z","canonical_url":"https://wefunder.com/neurohacker#question-74869","answers":[{"id":75028,"entity_id":"wefunder:comment:75028","answer":"Hi Sparkle. Thank you for your question and thank you for your prior investment! As far as exit strategy, there's 3 primary directions that we've considered. The first is to get acquired by a larger company that wants to continue the work and research that Neurohacker has started. This is probably the most likely option though we haven't begun actively pursuing this as we're currently still focused on growth more than exit. We've also considered staying private and beginning to pay out profit distributions to our shareholders once we're large enough that our cash flow allows for the ability to fund both growth and profits. Lastly, we've been courted by some investment bankers to go public. We're clear that this isn't something we would do right away as we're not large enough as an organization yet for this to make sense. However we could be within relatively short order based on the growth curves that we're seeing. As with any startup it's near impossible to predict exactly how we'll exit or the timing on it but given where we currently are as a company I'd expect an exit to happen in approximately 2-5 years.","author_name":"James Schmachtenberger","votes":0,"created_at":"2020-01-22T00:22:41Z"}]},{"id":52890,"entity_id":"wefunder:comment:52890","question":"What is your stance on dealing with liver health. Since a lot of nootropics get processed in the liver, is there anything you do to combat any strain on the liver?","author_name":"Josh McNare","votes":1,"created_at":"2019-05-13T02:22:32Z","canonical_url":"https://wefunder.com/neurohacker#question-52890","answers":[{"id":54252,"entity_id":"wefunder:comment:54252","answer":"Hi Josh. Nootropics are not alone; one of the liver's main jobs is processing and transforming compounds. It does this to compounds in the diet, molecules made in the course of normal metabolism, medications, toxins, etc. Many of the nootropic compounds included in Qualia (as well as ingredients in our new product Eternus) support the liver. Choline (as alpha GPC and Citicoline) is an example. The most common chronic liver disease is fatty liver. Chris Masterjohn has written several excellent articles on it. He's convinced that sub-optimal intake of choline is a huge part of the problem (https://chrismasterjohnphd.com/blog/2010/11/28/does-choline-deficiency-contribute-to/). We use two forms of choline in Qualia Mind (1 in Focus) along with several other nutrients (uridine as an example) that facilitate the choline cycle, which is important for both the brain and liver. Nutrients like PQQ, niacinamide and acetyl-L-carnitine are mitochondrial nutrients: they support mitochondrial function in all cells, brain and liver included. The coffee berry we use as a source of caffeine, similar to coffee, because of also including coffee polyphenols, is liver supportive. Artichoke, long before being thought of as a nootropic, was used for liver function by naturopathic doctors and herbalists. These are just a few examples. But the key point is that the brain, like the liver, makes many of the molecules it needs locally and is a very metabolically active tissue. Because of this, there's a big overlap of compounds that help both perform better. We give preference to ingredients that do more than one thing (we use a whole systems science approach). One result of this philosophy is that the nootropics we focus on tend to be things that support better liver health as well as brain performance.","author_name":"James Schmachtenberger","votes":0,"created_at":"2019-05-30T18:01:17Z"}]},{"id":51364,"entity_id":"wefunder:comment:51364","question":"Just enquiring about a recent look into your Amazon reviews through a site called fakespot: https://www.fakespot.com/product/qualia-mind-from-the-neurohacker-collective-premium-nootropic-supplement-for-mental-performance-brain-health-designed-to-optimize-brain-function-increase-focus-mental-clarity-boost","author_name":"Nathan McHugh","votes":1,"created_at":"2019-04-26T22:33:16Z","canonical_url":"https://wefunder.com/neurohacker#question-51364","answers":[{"id":51604,"entity_id":"wefunder:comment:51604","answer":"Hi Nathan. That one's hard for me to speak to since I'm not familiar with the site or what information they use to determine the quality of reviews. On Amazon we don't have control over the reviews that people leave so I'm not sure what this site bases the information on. We have asked Amazon if they would remove certain reviews that appeared to be written by competitors though if memory serves they've only agreed to remove 1 where the review was pretty egregious.","author_name":"James Schmachtenberger","votes":1,"created_at":"2019-04-30T00:13:44Z"}]},{"id":49890,"entity_id":"wefunder:comment:49890","question":"Did you change the terms of the early bird investment? It was up to $200k last week and it doesn't show up anymore.","author_name":"Brian Franklin","votes":1,"created_at":"2019-04-17T17:33:57Z","canonical_url":"https://wefunder.com/neurohacker#question-49890","answers":[{"id":51140,"entity_id":"wefunder:comment:51140","answer":"Hi Brian. We didn't change the terms of the early bird. What happened was that a couple people invested large amounts and because of the amounts it didn't post to the profile until WeFunder was able to confirm the investments. Even though the investments hadn't posted to the profile, they already took us over the $200k early bird amount.","author_name":"James Schmachtenberger","votes":0,"created_at":"2019-04-24T20:06:16Z"}]},{"id":43743,"entity_id":"wefunder:comment:43743","question":"When does this round finish? Is the 40 million tge limit for this round?","author_name":"Nathan McHugh","votes":1,"created_at":"2019-04-09T16:42:33Z","canonical_url":"https://wefunder.com/neurohacker#question-43743","answers":[{"id":43854,"entity_id":"wefunder:comment:43854","answer":"Hi Nathan. We don't have a set end date for the round at the moment. It largely depends on how quickly we get enough funding in to close the round, though we're expecting that the WeFunder raise will only be open for approximately 2 months total. This round is structured as a convertible note with a cap of $45 million but we've created a discount for the first $200k worth of investments where that's capped at $40 million. At the moment we're just under half of the way to that target so there's still a little time to invest at the discounted rate.","author_name":"James Schmachtenberger","votes":1,"created_at":"2019-04-10T02:05:42Z"}]},{"id":28834,"entity_id":"wefunder:comment:28834","question":"I'm just curious when we will be able to get the records saying we invested and the perks (if we applicable)?","author_name":"Jesse Rowe","votes":1,"created_at":"2018-10-11T15:35:27Z","canonical_url":"https://wefunder.com/neurohacker#question-28834","answers":[{"id":43855,"entity_id":"wefunder:comment:43855","answer":"Hi Jesse. I apologize for not answering this sooner. You're question didn't show on my interface until now though I see you posted it a few months ago. I'm guessing you've already received everything at this point but if for any reason you haven't please email invest@neurohacker.com and we'll make sure to get you what's needed.","author_name":"James Schmachtenberger","votes":0,"created_at":"2019-04-10T02:07:22Z"}]},{"id":12908,"entity_id":"wefunder:comment:12908","question":"how much does it cost people?","author_name":"Jim Billings","votes":1,"created_at":"2017-09-08T23:01:19Z","canonical_url":"https://wefunder.com/neurohacker#question-12908","answers":[]},{"id":11843,"entity_id":"wefunder:comment:11843","question":"Hi Jordan, Huge fan of the what the company is doing and definitely excited for all that's coming in the future. This will be my first investment on Wefunder and literally my first investment ever. I'm looking at investing $1000. I just need to know how this works before i jump right in 1) So i am betting that the company will be more then $20M in the future. and whenever that happens i'll make a return? How much am i looking at down the road if this appears to be successful? 2) How do i roughly calculate the returns assuming the company is worth 20M in the future? 3) I read one of your comments below stating that the company plans to return the capital..Will this be in the form of return of investments assuming the company hits the $20M mark? 4) How do i sell the returns i make if this appears to be successful down the road? I understand my questions may seem odd, but that's just because i am really new to all this. For the past couple years from the age of 22 i've been wanting to invest in an excellent startup company but nothing really seemed impressive enough for me to make an investment. I was introduced to Wefunder a couple days ago through the newsletter i received from Neurahacker about this campaign. So i'm really excited to be an investor. I look forward to hearing back from you PS: I read the risks section and i am fully aware that i'm investing what i'm willing to loose Healthy regards, Selven(Pronounced Selvein)","author_name":"Selven Dhiiran","votes":1,"created_at":"2017-08-10T16:58:30Z","canonical_url":"https://wefunder.com/neurohacker#question-11843","answers":[{"id":11924,"entity_id":"wefunder:comment:11924","answer":"Hi Selvan, sorry for the delay - I just got back from the Healthspottr conference. So . . . 1) Actually, the valuation of this round will be at most $20M. If our next raise is at, say $18M, then the valuation of this round will be 80% of that ($14.4M). For you get a return on your investment, we will need to either have a liquidity event (sometimes called an \"exit\") at a valuation higher than the valuation you invested at *or* provide a cash payment to investors (e.g., dividends) that exceed the amount of your investment. Your actual returns will depend on (a) the final valuation of this round (max $20M); (b) additional rounds of investment and how much they dilute existing shareholders; (c) final valuation at an exit OR (d) actual \"dividends\". Assuming the final valuation of this round is $20M and there are no more rounds and the company exits at $40M, then you would have a 200% return on your investment. 2) To roughly calculate returns, you take the valuation at exit and divide by the valuation at your investment (see above). Note, this is very rough because each additional round of investment (say we raise $15M in two years at a $80M valuation) adds more shares to the company. 3) The hope is to find a way to \"cash out\" investors through something akin to dividends out of cashflows. This would not reduce your ownership of the company - but it would get your cash back. *Then* any additional dividends or liquidity at an exit would be upside. 4) Your returns will be in the form of USD. The way this works is that you turn your cash (USD) into equity in a company (in this case NHC). The company uses that to try and create value - which will show up in an increased valuation - but even if the valuation is high (say $1Bn) *you* don't necessarily get to do anything with that (besides feel good) *until* there is some kind of liquidity event - which means until there is some event that brings cash back to you. Typically there are three kinds of liquidity event: a) We sell the company to someone else for cash. b) We make it possible for you to sell your equity to someone else for cash (e.g. an IPO or a stock buyback) c) We pay you cash as a dividend Hope this helps.","author_name":"Jordan Greenhall","votes":4,"created_at":"2017-08-13T16:10:08Z"}]},{"id":11432,"entity_id":"wefunder:comment:11432","question":"Dear Jordan Greenhall, Where are you in terms of FDA approval? Unlike pharmaceutical drugs the FDA doesn't give approval to, nor have an approval process for products in our space. They do mandate fairly stringent manufacturing, testing and quality assurance procedures. For this, we contract GMP (Good Manufacturing Practice) certified contract manufacturers to help ensure that FDA standards are met and where reasonably possible are exceeded. --------- We both know this is not true. You've been selling Qualia to thousands of customers as a DIETARY SUPPLEMENT, while it's a PHARMACEUTICAL DRUG. You probably aware of the fact, that Noopept doesn't meet DSHEA? Mixing synthetic, prescription drug(prescribed drug in Russia, NDA not filed in US) with herbs doesn't make Qualia a dietary supplement. It's like mixing Sildenafil(Viagra) with Fenugreek and calling it a dietary supplement for erectile dysfunction. You didn't even list that 30mg of Noopept/day is a high dosage, you didn't list all potential side effect of Noopept, you don't mention that Noopept shouldn't be taken longer than 2 months (yet you offer subscriptions). Noopept works, no doubt here, but will other ingredients in Qualia work after you remove Noopept? It'd be honest to tell your investors, that's really expensive to file NDA and it takes years of clinical trials etc before/if FDA allows you to start selling it....if you want to comply with US law, of course. Happy fundraising.","author_name":"Max Levskiy","votes":1,"created_at":"2017-07-28T19:33:06Z","canonical_url":"https://wefunder.com/neurohacker#question-11432","answers":[{"id":11451,"entity_id":"wefunder:comment:11451","answer":"\"Thanks for your follow up question Max. It's always good to see people with an eye for detail and with an obvious concern for public safety and accurate information. We also hold a strong desire for accurate information and hold public safety as utterly imperative. Towards that effect let me try to answer each of your questions. As far as disclosing safety data related to noopept and other ingredients in Qualia, we provide detailed information on our website regarding the studies that have been done on each ingredient. Elements of this are on the formulation page, with additional safety data on the product page - under safety data. To the best of my knowledge we offer more detailed safety data regarding our product than any company in our space. As far as the classification of noopept and Qualia as a whole, noopept is not a drug in the US. Many ingredients are classified differently in different countries and it doesn't carry from one to the other. By contrast, sildenafil is a drug in the US and therefor would have to be sold as such. Noopept is also not a racetam. It lacks the defining (https://en.wikipedia.org/wiki/Racetam) core pyrrolidone ring that defines the class. It is a modified di-amino acid peptide (L-prolylglycine). As with many ingredients there's potential for interpretation as to classification as well as potential for changes in classification (i.e. ephedra). For this reason we offer a fairly lengthy set of disclosures in our investment disclosures section related to potential regulatory risks. With that said, we've spent many hours of research and many thousands of dollars in legal consults to determine that the classification we're using are accurate. \"","author_name":"Jordan Greenhall","votes":2,"created_at":"2017-07-29T14:18:09Z"}]},{"id":309544,"entity_id":"wefunder:comment:309544","question":"Hello fellow investors, I was part of the 2019 funding round and have been a long-term supporter. For personal financial reasons, I am looking to sell my small stake in the company. If any existing shareholders are interested in increasing their position, or if you missed out on previous funding rounds and wish to have a stake in the company, please feel free to reply to this comment, and we can find a way to connect privately. As per Wefunder's rules, the legal transfer would be handled through their support team.","author_name":"Brooks Yardley","votes":0,"created_at":"2025-06-11T16:11:52Z","canonical_url":"https://wefunder.com/neurohacker#question-309544","answers":[]},{"id":304731,"entity_id":"wefunder:comment:304731","question":"What is the latest news for investors? I have never received communications or contacts since my April 08, 2019 investment via WeFunder.","author_name":"Jessica Behrman","votes":0,"created_at":"2025-03-26T22:23:14Z","canonical_url":"https://wefunder.com/neurohacker#question-304731","answers":[{"id":305220,"entity_id":"wefunder:comment:305220","answer":"Hi Jessica. Thank you for being an investor in Qualia! We've been posting quarterly updates to this platform for all investors which can be found at: https://wefunder.com/neurohacker/updates Once you've had a chance to review the updates, if you still have any questions you can message us at support@qualialife.com","author_name":"James Schmachtenberger","votes":0,"created_at":"2025-04-02T17:28:24Z"}]},{"id":289276,"entity_id":"wefunder:comment:289276","question":"I read that Neurohacker Collective is changing its name to Qualia Life Sciences. How does this change affect the investors who invested through We Funder platform?","author_name":"Faryal Ijaz","votes":0,"created_at":"2024-08-01T08:30:33Z","canonical_url":"https://wefunder.com/neurohacker#question-289276","answers":[]},{"id":173926,"entity_id":"wefunder:comment:173926","question":"If/When an investment opportunity arises, where would be the best place to follow for updates? E.g. if the investment opportunity comes up, would it be shared on social medias like facebook and instagram?","author_name":"James McCabe","votes":0,"created_at":"2021-10-13T13:13:02Z","canonical_url":"https://wefunder.com/neurohacker#question-173926","answers":[{"id":179473,"entity_id":"wefunder:comment:179473","answer":"Hi James. Thank you for your interest in making an investment! If we decide to raise another round of financing from non-institutional investors, we will notify our customers by email of this opportunity. Meanwhile, thank you for being a customer!","author_name":"James Schmachtenberger","votes":0,"created_at":"2021-11-15T19:49:44Z"}]},{"id":153195,"entity_id":"wefunder:comment:153195","question":"Do you have another investment opportunity open soon ?","author_name":"Walter Grohs","votes":0,"created_at":"2021-06-08T19:45:57Z","canonical_url":"https://wefunder.com/neurohacker#question-153195","answers":[{"id":164481,"entity_id":"wefunder:comment:164481","answer":"Walter, Thank you for your interest! No, currently we are not planning a new crowdfunding investment round. We'd consider offers of institutional investment, though. Happy investing!","author_name":"James Schmachtenberger","votes":0,"created_at":"2021-08-19T19:27:11Z"}]}],"faq":[{"question":"Being a user of your product and a fan of crowd sourcing, I was pretty excited to see you guys pop on WeFunder. My question for you is, how did you come to a valuation of $20 million? I feel like the valuation is rather high and brings a chance for return on investment could b...","answer":"Thanks! To answer your first question, requires looking at NHC from two directions. From the bottom, we look at valuation in terms of the stage the company has reached. In classic startup terms, we’ve blown through the first few startup gates; i) creating an awesome team, ii) launching a an alpha product, iii) first revenues, and iv) evidence of potential to scale with a mix of existing and burgeoning revenue generating channels. With more than $2M in the trailing twelve months and a high gro..."},{"question":"I'm with Hunter on the $500 minimum and with Barnaby on not being a fan of SAFEs for non-tech startups. A convertible note or straight equity would be better. The SEC outlines some very good concerns with the inappropriateness of SAFEs for certain investments here https://www....","answer":"Fundamentally, we believe the opportunity we're offering here is more about the vision, team, traction, and market opportunity, and less about boiler plate documents. For clarity, the SAFE agreement is a doc designed for and by the the startup marketplace by venture investors as a standard by which early-stage, or seed investors and founders could move quickly and effectively towards agreement. As noted by the SEC in the Bulletin that you refer to the various mechanisms of the SAFE were desig..."},{"question":"$1,000+ Membership in our product Beta test group... Will we get to test new products for free? Approximately how long will testing periods be? Does each tier include the previous tier perks?","answer":"Hi Jeromi. Yes, you will get to test new products for free. Testing periods will vary widely by the kind of product and the stage of testing. You can sign up for as much or as little as you like. Yes, the tiers are cumulative!"},{"question":"Are there any financials to look at? Current and/or projections...","answer":"Hi Lev, you can find the complete 2016 financials on the Form C. https://www.sec.gov/Archives/edgar/data/1707359/000167025417000170/document_4.pdf For 2017, I recommend you expand the various Q\u0026amp;A questions above and look at the financially targeted ones. Good data to be found there."},{"question":"It seems like your team is largely comprised of entrepreneurs and marketing professionals. What medical credentials does your team have, and what safeguards have you put in place to ensure this is a scientifically vetted product, and not just we'll branded snake oil? Asking as...","answer":"Hey Keith, our Website has a better view into the deeper scientific/medical team behind the collective: http://neurohacker.com/ethos/ Some specific people of note: Dan Stickler, MD was a surgeon and got into longevity medicine and the nootropics space. Andrew Huberman, PhD, Stanford School of Medicine Sara Adaes, PhD in neurobiology is a full time contractor doing research for Neurohacker Collective. Shawn Ramer, PhD biochemist with pharma and healthcare experience is an advisor we brought on..."}]}}}